Introduction.
Atrial fibrillation (AF) is common in patients following cardiac surgery (CS). The incidence of post-CS AF ranges from 15-42%, 1 with the arrhythmia usually occurring 2-3 days post-CS. 1 It is associated with an increased incidence of stroke, poor haemodynamic performance, and increased morbidity and mortality. 2 The electrophysiological mechanisms of post-CS AF are not known.
The occurrence of post-CS AF is independently predicted by old age, post-CS withdrawal of betaadrenoceptor antagonist (β-blocker) treatment, pre-CS AF, valve surgery, P-wave changes, and numerous other clinical factors. 1, 3, 4 Thus, in addition to surgical procedures and drug treatments, the pre-existing (pre-CS) characteristics of patients, and indeed their atria, influence the incidence of this arrhythmia.
It is presently unclear whether pre-CS atrial cellular electrophysiology is predictive of post-CS AF. The pre-CS inward rectifier K + currents, I K1 and I KACh , were similar in atrial cells from patients who did and did not develop post-CS AF. 5 By contrast, the pre-CS L-type Ca 2+ current (I CaL ) was larger, 6 and the transient outward (I TO ) and ultra-rapid delayed rectifier K + (I Kur ) currents tended to be smaller, 7 in cells from those with post-CS AF. In patients, the pre-CS atrial effective refractory period (ERP) was shorter in those who developed post-CS AF, 8 suggesting that the action potential duration (APD) might also be shorter in such patients. However, an increase in I CaL , a decrease in I TO and I Kur , or both would lengthen, rather than shorten the APD. There are currently no reported studies of pre-CS action potentials or ERP in atrial cells from patients who develop post-CS AF.
Administration of β-blockers pre-CS reduces the incidence of post-CS AF. 9, 10 Since sympathetic activity is high post-CS, 11 it is possible that β-blockers are anti-arrhythmic in this setting as a consequence of their block of this enhanced sympathetic activity. However, we recently demonstrated that atrial myocytes from patients in pre-CS SR who had been given β-blockers, exhibited a prolonged APD and ERP that may be a consequence of pharmacological remodelling. 12 It is unknown whether these pre-CS electrophysiological changes confer protection against post-CS AF, but it has been shown that other drugs with Class III antiarrhythmic action reduce the incidence of post-CS AF. 13 It is conceivable that the degree of pre-CS ERPlengthening produced by pre-CS β-blockade might be greater in the patients who remain in sinus rhythm (SR) post-CS than in those who develop AF.
The aims of this study, therefore, were two-fold. Firstly, to establish whether pre-CS human atrial cell action potential characteristics, ERP and ion currents differ between patients who do and do not develop new-onset post-CS AF, including or excluding patients with co variables expected to influence post-CS AF incidence and/or pre-CS electrophysiology. Secondly, to compare the degree of pre-CS APD-and ERPprolongation associated with pre-CS β-blockade, between patients who do and who do not develop post-CS AF.
Methods.
Right atrial appendage tissue was obtained from 212 consenting patients in SR undergoing cardiac surgery between 1999 and 2005. Procedures were approved by the institutional research ethics committee.
Atrial cells were isolated using a method previously described in detail, 14 increasing from -40 mV to +60 mV in 10 mV steps. I SUS was measured as end-pulse current magnitude, and I TO as peak outward minus end-pulse current. I SUS was considered to reflect mainly I Kur , 18 but also includes various Ca 2+ -dependent and -independent currents. 15, 18, 19 The various components of I TO or I SUS were not separated in the present study. I K1 was measured using linear voltage ramps increasing from -120 mV to +50 mV at 24 mV/s, or with 500 ms voltage pulses (0.2 Hz) increasing from -120 mV to +50 mV, from an HP of -50 mV. All currents were normalised to cell capacity.
Details of each patient's clinical characteristics and drug treatments were obtained from the medical records, post-CS, and are shown in Table 1 . Sinus rhythm was confirmed from a pre-CS 12 lead ECG. Each patient's cardiac rhythm, heart rate and drug treatments were assessed on the day of surgery, on the preceding day, and post-CS between 1 and 7 days. The early (0-3 day) period after CS was used to compare data between patients with and without post-CS AF whenever sample size permitted, i.e. for all measurements except I K1 , I SUS and the effect of ISO on I CaL , for which the 0-7 day period was used. Patients were excluded from the analysis if they had a documented episode of AF at any time pre-CS, if they were taking digoxin, or if their pre-CS β-blocker treatment had started later than 7 days before the day of surgery.
Patient and associated cellular electrophysiological data were stored in a database (Access, Microsoft) for subsequent analysis.
Statistical methods.
Univariate measurements were compared between pairs of various subgroups of patients using 2-sided, 2-sample unpaired Student's t tests. Categorical data were compared using a χ 2 test. All univariate electrophysiological data are expressed as cell means±1 standard error (SE) of the mean. All cell means and associated P values (from the t-tests) were confirmed at subject level, by meaning all cell data obtained from each patient prior to meaning patients' data. Multiple linear regression 20 was used to further investigate associations between patients' atrial electrophysiology and clinical characteristics or drug treatments. This provided an estimate of the difference in each electrophysiological measurement between the levels of the factor of interest, according to 10 variables considered to be of particular importance. Multiple logistic regression models were used to investigate the influence of both the clinical factors and the electrophysiological covariates on the occurrence of post CS AF. All analyses were performed retrospectively, using SAS 9.1 for Windows software (SAS Institute, Cary, NC, USA). The analyses incorporated all available information. Therefore, the tables and the statistical models are sometimes based on different numbers of subjects, reflecting some missing data for some covariates. Only patients from whom cellular electrophysiological data were obtained were included in the study. No adjustment was made for multiple comparisons. P<0.05 was regarded as statistically significant.
Results.
Post-cardiac surgery atrial fibrillation was predicted by older patient age.
Post-CS AF occurred in 53 (25%) of the 212 patients from whom atrial cellular electrophysiological recordings were obtained. ISO also was similar between these patient groups (P=0.95, Figure 1C ). days pre-CS was associated with a significant prolongation in both action potential late repolarisation and ERP: the APD 90 and ERP were 193±8 and 192±8 ms, respectively, in the non-β-blocked patients (n=31) vs 230±7 and 234±6 ms, respectively, in the β-blocked patients (n=58, P=0.001 for each). This prolongation was independent of holding current (-0.74±0.07 and -0.68±0.03 pA/pF in non-β-blocked and β-blocked patients, respectively; P=0.38), and was also confirmed by multiple regression analysis, with an estimated increase in ERP by β-blockade of 36 ms (P=0.027). Action potential characteristics and ERP were therefore compared within sub-groups of patients, internally matched for age, who were treated and not-treated pre-CS with a β-blocker, respectively. No significant differences were revealed between patients who did and who did not develop post-CS AF in either sub-group. Furthermore, this outcome was unchanged by the exclusion from the analysis of patients either who had the β-blocker treatment they received pre-CS withdrawn within 3 days post-CS, or were given a β-blocker for the first time within the same post-CS period.
Pre-CS atrial K
Three multiple regressions were fitted to further investigate associations between patients' clinical characteristics and action potential shape and ERP. Firstly, taking into account all co variables, ie: as for those in Table 3 . Secondly, taking into account only 4 co variables considered the most likely to influence post-CS AF. Thirdly, taking into account only age (shown in Table 2 
Discussion.
This study is the first, to our knowledge, in which pre-CS human atrial action potentials have been compared between patients who do and do not develop post-CS AF. Earlier studies of changes in patients' pre-CS electrocardiograms associated with post-CS AF showed prolongation of the P-wave duration (P dur ) and/or P-R interval, 8, 21 though a lack of prolongation and an increase in P-wave complexity also were found. 4 The present study indicates that APD changes do not contribute to the prolongation of P dur , which may be due to altered intra-atrial conduction velocity (θ) or atrial size. Reduction in the action potential V max may cause θ-slowing, but the present lack of a difference in V max suggests that any slowing of θ associated with post-CS AF occurs by other mechanisms, such as changes in expression of gap junction proteins. 22 A clinical study demonstrated an association between post-CS AF and a shorter, spatially heterogeneous pre-CS ERP, 8 in contrast to the present data which do not support pre-CS ERP-shortening as being predictive of post-CS AF.
The measurement of ERP in isolated cells has limitations compared to that made in-vivo, and does not inform about conduction or spatial heterogeneity. 23 However, the relevance of this measurement was supported by the demonstration that pre-CS chronic AF was associated with its shortening, 14 and by a similar magnitude to that in the right atrial appendage in patients in-vivo. 24 The similarity in each of the atrial ion currents measured pre-CS, between groups of patients who did and who did not develop post-CS AF, is consistent with the lack of change in any action potential measurements or the ERP. Our data are also in agreement with a previous report of a lack of difference in human atrial I K1 between such patient groups. 5 There is one previous report that pre-CS atrial I CaL was significantly larger in patients who developed post-CS AF, than in those who did not. 6 The reasons for this discrepancy are unclear, though they may include differences in the clinical characteristics of the patients studied. For example, those who developed post-CS AF in the earlier study 6 were of a similar age to those who remained in SR. It was also noted 6 that there was a substantial overlap in the Ca 2+ current density data between the groups of patients with and without post-CS AF. It is worth noting that the present and other [5] [6] [7] analyses of post-CS AF include only patients in pre-CS SR. Pre-CS AF, however, is well established to be accompanied by atrial electrophysiological changes, including decreased I CaL , 6,14 I TO 7,14 and ERP, 14 and increased I K1 . 5, 14 Nevertheless, such changes and, therefore, any potentially associated predisposition to AF,
were not found pre-CS in patients in SR who develop post-CS AF.
Long term treatment of patients pre-CS with a β-blocker was associated retrospectively with a significant reduction in the incidence of post-CS AF, in line with previous prospective studies. 9, 10 Pre-CS chronic β-blockade also was associated with a significant prolongation in the pre-CS atrial cell APD and ERP, consistent with an earlier report from our laboratory. 12 Those electrophysiological changes, recorded in the presumed absence of residual β-blocker (since cells had been isolated and washed), and independent of heart rate, reflect an adaptive response, which has been termed pharmacological remodelling. 12 This is distinct from reversal of AF-induced remodelling, 25 since it occurred in cells from patients in SR. Such β-blocker-induced ERP-prolongation, by lengthening the minimum path length required for atrial re-entry, might contribute to the anti-fibrillatory actions of β-blockers. 26 In the present findings, the degree of atrial ERP-prolongation associated with pre-CS chronic β-blockade was virtually identical in the patients who did and did not develop post-CS AF. This suggests that the atrial anti-fibrillatory effects of pre-CS β-blockade
were not due to enhanced pharmacological remodelling in the patients who remained in post-CS SR.
However, action potential and ion current properties measured pre-CS may not reflect those present in patients in AF post-CS, and an enhanced post-CS ERP-prolongation in the β-blocked patients who maintained SR cannot be excluded. Furthermore, it is conceivable that any such anti-reentrant influence could nevertheless be overcome by a focal arrhythmic mechanism. The present experiments with ISO suggest that such a focal mechanism would not involve any enhancement of the pre-CS I CaL response to catecholamines.
The causes and predictors of post-CS AF are complex and multifactorial. The arrhythmia is re-entrant, with a variety of electrophysiological onset mechanisms, but with the final trigger in the majority of cases being a conducted atrial extrasystole. 3 Post-CS AF seems to be caused mainly by the surgical procedure itself, sensitised by the pre-existing influence of age on atrial electrophysiology, and modified by pre-and post-CS drug treatments. The surgical causes are considered to be the effects of circulating catecholamines, imbalances in autonomic tone (including parasympathetic resurgence), transient electrolyte imbalance, myocardial ischaemia, inflammation and mechanical irritation. [27] [28] [29] [30] [31] Older age may pre-dispose the atrium to re-entry by slowing θ 32 as a result of atrial atrophy, dilation and/or fibrosis, 33 rather than by slowing atrial cell action potential V max . Atrial structure was not examined in the present study, and pre-CS structural changes have been associated with the development of new onset post-CS AF, including atrial enlargement, 34 increased fibrosis, 33 and up regulation of type I collagen 35 and connexin40. 22 Persistent AF is accompanied by atrial structural changes which may contribute to the perpetuation of the arrhythmia independently of ERP changes. The precise nature of these structural changes, termed the "second factor" of AF 36 remains unclear, but similar changes pre-CS could conceivably promote new onset post-CS AF.
The present data indicate that the occurrence of post-CS AF is not predicted by pre-CS atrial cellular electrophysiology. Furthermore, since pre-CS β-blockade reduced the incidence of this arrhythmia without an involvement of β-blocker effects on the pre-CS ERP, mechanisms independent of pre-CS ERP change, such as attenuation of triggered atrial extrasystoles, are likely to underlie the post-CS atrial anti-arrhythmic effects of β-blockers. Table 4 . +BB=5). †s denote P<0.05 for the increase in ERP associated with pre-CS β-blockade within each group. Table 1 Table 2   Table 3   Table 4 Clinical factor Level Odds ratio (95% CI) 
